Weight Maintenance After Injectable Orforglipron ATTAIN-MAINTAIN demonstrated that patients switching from injectable tirzepatide or semaglutide to orforglipron maintained their weight loss, validating oral step-down therapy
Overall, more research will be necessary to see what the right move is, and potentially even develop an SSRI that works better alongside GLP-1 drugs like semaglutide
Youve heard about semaglutide, for sure
Insulin resistance can be a key contributor to all these issues and many more
For skin-related goals, consistent daily use is usually needed for several weeks, alongside sunscreen, hydration, and a balanced diet
Typical research areas include: In vitro studies using cell lines or isolated islets to measure insulin secretion, beta-cell viability, cAMP signaling, and responses to metabolic stress